Pharmacokinetics, Safety and Immunogenicity of RPH-104 at a New Dosage and Different Doses Via Single Subcutaneous and Intravenous Administration in Healthy Volunteers

solution for intravenous injection, 40 mg/mL

solution for intravenous injection, 40 mg/mL

solution for intravenous injection, 40 mg/mL

solution for subcutaneous injection, 80 mg/mL

solution for subcutaneous injection, 40 mg/mL

solution for subcutaneous injection, 80 mg/mL

0.9% Sodium Chloride solution for Injection